The HinduLean L·
Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company
$250 million acquisition of the Pennsylvania-based generic pharmaceutical firm expected to be completed before June, says Aurobindo
Read at The Hindu →
$250 million acquisition of the Pennsylvania-based generic pharmaceutical firm expected to be completed before June, says Aurobindo

<iframe src="https://hindustansphere.com/embed/cluster/8f6f19ca0a0b7ccc3aab1056afd8a0c873974e0c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company"></iframe>
